Thought Leadership2018-10-15T14:23:33-05:00

News & Events

Observations, opinions, and opportunities presented by our experts


Precision-Led Working Group Provides Suggestions to Close Gaps When Creating Value Frameworks for New Medical Therapies

Randomized controlled trials don’t capture real-world evidence regarding how patients will actually interact with, adhere to, or find value in a costly new medical therapy, yet current value frameworks and assessments don’t include this “real world” element. A new working group led by PHE’s Anupam Jena, Jacki Chou, and Darius Lakdawalla aim to improve this dynamic by offering guidance on closing the gap between real-world and clinical trial data when formulating value frameworks.


Rapid Diagnostics for Rheumatoid Arthritis Study Published in Journal of Medical Economics Article

PHE recently published a new study in collaboration with Genalyte on the potential value of rapid, cloud-enabled, onsite laboratory testing for the diagnosis of rheumatoid arthritis. The study found that this technology could generate value of over $5,000 per evaluated patient-year. The study was led by PHE’s Kata Bognar, Jason Shafrin, Michelle Brauer, Lauren Zhao, and Bapu Jena. […]

PHE’s Huber Leads New Study on Social, Economic Impacts of 2014 Ebola Crisis

Led by Caroline Huber, Associate Director of Policy and Economics, a surprising new study was recently published in The Journal of Infectious Diseases, estimating the overlooked social, economic and health impacts of the 2013-2016 West Africa Ebola crisis.


PHE’s Shafrin in JCP: Three Key Challenges to Make Precision Benefit Design Patient-Centered

In a new editorial for the Journal of Clinical Pathways, Jason Shafrin addresses the appeal of precision benefit design, identifying three key challenges to patient-centered implementation. […]

Load More Posts

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

By continuing to use our website, you agree to our use of cookies to help us give you the best experience, analyze your site usage, and assist in our marketing efforts.
For more information, or to learn how to change your cookies preferences, please click here.